Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?

Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?
Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment? Expert Opin Drug Deliv. 2019 Oct 30;: Authors: Rehman S, Nabi B, Zafar A, Baboota S, Ali J Abstract Introduction: Intranasal drug delivery is a largely unexplored, promising approach for the treatment of various neurological disorders. However, due to the challenging constraints available in the pathway of nose-to-brain ... read more
Source: PubMedPublished on 2019-10-31